relative to disbursement of funds by the New Hampshire vaccine association.

HB 524 repeals the New Hampshire Vaccine Association (NHVA), a state program that collected funds from insurance companies to help cover the cost of childhood vaccines for privately-insured children under 19. After repeal, healthcare providers will directly purchase vaccines for these children and bill insurers directly, ending the state’s annual $24 million revenue stream from the NHVA. The state will also need to fund vaccines for public health emergencies (estimated at $150,000 in the first year), as it will no longer receive NHVA reimbursements for vaccine costs. Insurance companies, which previously saved about 30% on vaccine prices through the NHVA, may face higher costs and potential premium increases for families.